HRT2 Antibodies

Santa Cruz Biotechnology provides a broad selection of HRT2 monoclonal antibodies for research focused on understanding HRT2 protein functions. The monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). HRT2, or Hypoxia Response Transcription Factor 2, plays a critical role in cellular responses to hypoxic conditions, regulating gene expression that is essential for adaptation to low oxygen levels. HRT2 significantly influences various physiological processes, including angiogenesis and metabolic regulation, making it a key target for research in cancer and other diseases where hypoxia is a factor. Understanding HRT2 function can provide insights into therapeutic strategies aimed at modulating its activity. Research utilizing HRT2 monoclonal antibodies has revealed important mechanisms in oxygen sensing and cellular adaptation pathways. Scientists continue to uncover new roles for HRT2 in disease progression and potential therapeutic applications. Ongoing studies with HRT2 monoclonal antibodies have highlighted its importance in tumor development and progression. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific understanding of hypoxia-related cellular processes and disease mechanisms.